Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1997;28:2513-2517

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ikezaki, K.
Right arrow Articles by Fukui, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikezaki, K.
Right arrow Articles by Fukui, M.
Right arrowPubmed/NCBI databases
*OMIM

(Stroke. 1997;28:2513-2517.)
© 1997 American Heart Association, Inc.


Articles

A Clinical Comparison of Definite Moyamoya Disease Between South Korea and Japan

Kiyonobu Ikezaki, MD, PhD; Dae Hee Han, MD, DMSci; Teruaki Kawano, MD, PhD; Naoko Kinukawa, MS; Masashi Fukui, MD, PhD

From the Department of Neurosurgery (K.I., M.F.), Neurological Institute, Medical Information Center (N.K.), Kyushu University Faculty of Medicine, Fukuoka Tokushukai Hospital (T.K.), Fukuoka, Japan, and Department of Neurosurgery, Seoul National University, Seoul, South Korea (D.H.H.).

Background and Purpose The goal of the present study was to clarify whether South Korean patients with moyamoya disease have clinical features similar to those of Japanese patients.

Methods From 26 South Korean neurosurgical institutes, 296 definite cases were collected and analyzed statistically. These cases were then compared with 731 Japanese definite cases registered to the Research Committee on Moyamoya Disease of the Ministry of Health and Welfare, Japan.

Results The Korean age distribution patterns showed two peaks that were similar to those seen in Japanese patients. The incidence of adult moyamoya disease in South Korea, however, was 20% higher than that in Japanese patients. The family occurrence rate was 1.8% in Koreans. The incidence of cerebral infarction and bleeding in Koreans was statistically higher, whereas transient ischemic attack and seizure were less than those in Japanese subjects. The incidence of infarction in children and that of hemorrhage in both children and adults were also statistically higher in Koreans. The incidence of hemorrhage was higher in females than in males. Both the age at onset and sex affected the disease type. Although most Japanese patients underwent direct bypass surgery and/or combined indirect bypass procedures, single encephaloduroarteriosynangiosis was performed on 87.6% of all surgical cases in Koreans. Despite the higher incidence of hemorrhagic type in South Korea, the outcomes of the patients were similar to those of the Japanese patients.

Conclusions This study suggests that the clinical background of moyamoya disease in South Korea is essentially similar to that in Japan.


Key Words: epidemiology • Japan • moyamoya disease • South Korea




This article has been cited by other articles:


Home page
LupusHome page
H. Jeong, Y. Kim, W Yoon, S. Joo, S. Lee, and Y. Park
Moyamoya syndrome associated with systemic lupus erythematosus
Lupus, July 1, 2008; 17(7): 679 - 682.
[Abstract] [PDF]


Home page
StrokeHome page
S. Kuriyama, Y. Kusaka, M. Fujimura, K. Wakai, A. Tamakoshi, S. Hashimoto, I. Tsuji, Y. Inaba, and T. Yoshimoto
Prevalence and Clinicoepidemiological Features of Moyamoya Disease in Japan: Findings From a Nationwide Epidemiological Survey
Stroke, January 1, 2008; 39(1): 42 - 47.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J. Francis, S. Raghunathan, and P. Khanna
The role of genetics in stroke
Postgrad. Med. J., September 1, 2007; 83(983): 590 - 595.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Uchino, S. C. Johnston, K. J. Becker, and D. L. Tirschwell
Moyamoya disease in Washington State and California
Neurology, September 27, 2005; 65(6): 956 - 958.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
E. Y. Yilmaz, M. B. Pritz, A. Bruno, A. Lopez-Yunez, and J. Biller
Moyamoya: Indiana University Medical Center Experience
Arch Neurol, August 1, 2001; 58(8): 1274 - 1278.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. Chiu, P. Shedden, P. Bratina, and J. C. Grotta
Clinical Features of Moyamoya Disease in the United States
Stroke, July 1, 1998; 29(7): 1347 - 1351.
[Abstract] [Full Text] [PDF]